Waters acquires Megadalton Solutions,Inc. to broaden CDMS technology application
![](https://www.bioanalysis-zone.com/wp-content/uploads/2022/02/BZ-News-800x345.png)
Waters Corporation (MA, USA) has announced its acquisition of the technology assets and intellectual property rights of Megadalton Solutions, Inc. (IN, USA), an early-stage developer of charge detection mass spectrometry (CDMS) technology and services Udit Batra, President and CEO of Waters Corporation, commented: “Large molecule mass spectrometry with CDMS offers an important tool for the characterization, analysis and quantification of next-generation biologics, such as cell and gene therapies, which is an area of high interest among biopharmaceutical and biomedical research customers.” You may also be interested in: KCAS to acquire FlowMetric, LLC to better serve cell and gene therapy programs...